Stone RM - Search Results

1

Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia.

Attar EC, De Angelo DJ, Supko JG, D'Amato F, Zahrieh D, Sirulnik A, Wadleigh M, Ballen KK, McAfee S, Miller KB, Levine J, Galinsky I, Trehu EG, Schenkein D, Neuberg D, Stone RM, Amrein PC. Attar EC, et al. Among authors: stone rm. Clin Cancer Res. 2008 Mar 1;14(5):1446-54. doi: 10.1158/1078-0432.CCR-07-4626. Clin Cancer Res. 2008. PMID: 18316568 Clinical Trial.

2

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

Rubin EH, Andersen JW, Berg DT, Schiffer CA, Mayer RJ, Stone RM. Rubin EH, et al. Among authors: stone rm. J Clin Oncol. 1992 Jun;10(6):948-53. doi: 10.1200/JCO.1992.10.6.948. J Clin Oncol. 1992. PMID: 1588374 Clinical Trial.

3

The unique aspects of acute promyelocytic leukemia.

Stone RM, Mayer RJ. Stone RM, et al. J Clin Oncol. 1990 Nov;8(11):1913-21. doi: 10.1200/JCO.1990.8.11.1913. J Clin Oncol. 1990. PMID: 2230879 Review.

4

The approach to the elderly patient with acute myeloid leukemia.

Stone RM, Mayer RJ. Stone RM, et al. Hematol Oncol Clin North Am. 1993 Feb;7(1):65-79. Hematol Oncol Clin North Am. 1993. PMID: 7680642 Review.

5

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schiffer CA. Stone RM, et al. N Engl J Med. 1995 Jun 22;332(25):1671-7. doi: 10.1056/NEJM199506223322503. N Engl J Med. 1995. PMID: 7760868 Free article. Clinical Trial.

6

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, et al. Stone RM, et al. J Clin Oncol. 1994 Dec;12(12):2535-42. doi: 10.1200/JCO.1994.12.12.2535. J Clin Oncol. 1994. PMID: 7989927

7

Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.

Stone RM, Mayer RJ. Stone RM, et al. Hematol Oncol Clin North Am. 1993 Feb;7(1):47-64. Hematol Oncol Clin North Am. 1993. PMID: 8449864 Review.

8

Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes.

Stone RM, Spriggs DR, Arthur KA, Mayer RJ, Griffin J, Kufe DW. Stone RM, et al. Am J Clin Oncol. 1993 Apr;16(2):159-63. doi: 10.1097/00000421-199304000-00017. Am J Clin Oncol. 1993. PMID: 8452111 Clinical Trial.

9

Trials of 9-amino-20(S)-camptothecin in Boston.

Eder JP, Rubin E, Stone R, Bryant M, Xu G, Supko J, Kinchla N, Lynch T, Hurwitz S, Rodriguez D, Shapiro C, Toppmeyer D, Grossbard M, Vosburg E, Huberman M, Schnipper L, Shulman L, Kufe DW. Eder JP, et al. Ann N Y Acad Sci. 1996 Dec 13;803:247-55. doi: 10.1111/j.1749-6632.1996.tb26394.x. Ann N Y Acad Sci. 1996. PMID: 8993518 Clinical Trial.

10

Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Friedberg JW, Neuberg D, Stone RM, Alyea E, Jallow H, LaCasce A, Mauch PM, Gribben JG, Ritz J, Nadler LM, Soiffer RJ, Freedman AS. Friedberg JW, et al. Among authors: stone rm. J Clin Oncol. 1999 Oct;17(10):3128-35. doi: 10.1200/JCO.1999.17.10.3128. J Clin Oncol. 1999. PMID: 10506609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

528 results

Search Page